Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer

被引:4
作者
Wang, Q. [1 ]
Ye, T. [1 ]
Chen, H-L. [1 ]
Zhang, X-G. [1 ]
Zhang, L-Z. [2 ]
机构
[1] Xuzhou Canc Hosp, Dept Radiotherapy, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Dept Radiotherapy, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
关键词
Breast cancer; Intensity modulated radiation therapy; Bone marrow suppression; RECURRENCE; THERAPY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To study the correlation factors of bone marrow suppression in breast cancer radiotherapy and find out the method to guide the target area, dose limitation for breast cancer to reduce the risk of bone marrow suppression. PATIENTS AND METHODS: 72 cases of breast cancer patients were collected through retrospective, clinical control study. For patients with Grade 0-3, bone marrow suppression in the course of radiotherapy, the dose-volume parameters (V5, V10, V20, V30, V50, D20, D40, D60, D80, D100, Min, Max, Dmean) of the chest and rib of each patient were collected and analyzed from multiple points including tumor stage, age, lesion location, surgical approach, chemotherapy regimen and the number of cycles, bone dose-volume parameters. RESULTS: The relative parameters of the rib in the middle and severe bone marrow suppression group were significantly higher than those in the mild bone marrow depression group and the p values of V5, V10, V20, V30, Dmean, D40, D60, D80, D100 were less than 0.05. The difference of V50 in the two groups was statistically significant (p <0.05). For chemotherapy regimens containing doxorubicin, epirubicin, cyclophosphamide, the differences between bone marrow suppression group and non-bone marrow suppression were statistically significant (p =0.002). CONCLUSIONS: The dose-volume parameters of the rib radiation is one of the main factors causing the suppression of bone marrow in radiotherapy, and the volume of the 50Gy irradiation is also a contribution to the bone marrow. For patients accepted chemotherapy with doxorubicin, epirubicin, cyclophosphamide before radiotherapy, bone marrow suppression is more likely to occur during radiotherapy. After radical mastectomy or the volume of thoracic rib is increased because of the small breast, the occurrence of bone marrow suppression is increased. The effects of radiation on the bone marrow suppression were small, while its effect on the ribs was more evident, especially on the ribs V20 and Dmean and the difference was statically significant.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [21] Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy technique in elderly breast cancer patients
    Chen, Kuan-Wen
    Hsu, Hsiu-Ting
    Lin, Jia-Fu
    Yeh, Hui-Ling
    Yeh, Dah-Cherng
    Lin, Chin-Yao
    Chan, Siwa
    Hsieh, He-Yuan
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S12 - S22
  • [22] Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients
    Alba Fiorentino
    Rosario Mazzola
    Niccolò Giaj Levra
    Sergio Fersino
    Francesco Ricchetti
    Gioacchino Di Paola
    Stefania Gori
    Alberto Massocco
    Filippo Alongi
    Aging Clinical and Experimental Research, 2018, 30 : 533 - 538
  • [23] Helical tomotherapy based intensity modulated radiotherapy for the management of difficult clinical situations in breast cancer
    Saha, Animesh
    Mahata, Anurupa
    Shrimali, Rajkumar
    Achari, Rimpa
    Mallick, Indranil
    Chatterjee, Sanjoy
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (04): : 543 - 547
  • [24] Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients
    Fiorentino, Alba
    Mazzola, Rosario
    Levra, Niccolo Giaj
    Fersino, Sergio
    Ricchetti, Francesco
    Di Paola, Gioacchino
    Gori, Stefania
    Massocco, Alberto
    Alongi, Filippo
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (05) : 533 - 538
  • [25] Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation
    Guttmann, David M.
    Gabriel, Peter
    Kennedy, Christopher
    Rate, William
    Grizos, William
    Nagda, Suneel
    Wojtowicz, Lisa
    Lin, Lilie
    Freedman, Gary M.
    BREAST JOURNAL, 2018, 24 (02) : 128 - 132
  • [26] ACCELERATED WHOLE BREAST IRRADIATION WITH INTENSITY-MODULATED RADIOTHERAPY TO THE PRONE BREAST
    Croog, Victoria J.
    Wu, Abraham J.
    Mccormick, Beryl
    Beal, Kathryn P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 88 - 93
  • [27] Intensity modulated radiotherapy for elderly bladder cancer patients
    Chen-Hsi Hsieh
    Shiu-Dong Chung
    Pei-Hui Chan
    Siu-Kai Lai
    Hsiao-Chun Chang
    Chi-Huang Hsiao
    Le-Jung Wu
    Ngot-Swan Chong
    Yu-Jen Chen
    Li-Ying Wang
    Yen-Ping Hsieh
    Pei-Wei Shueng
    Radiation Oncology, 6
  • [28] Intensity modulated radiotherapy for elderly bladder cancer patients
    Hsieh, Chen-Hsi
    Chung, Shiu-Dong
    Chan, Pei-Hui
    Lai, Siu-Kai
    Chang, Hsiao-Chun
    Hsiao, Chi-Huang
    Wu, Le-Jung
    Chong, Ngot-Swan
    Chen, Yu-Jen
    Wang, Li-Ying
    Hsieh, Yen-Ping
    Shueng, Pei-Wei
    RADIATION ONCOLOGY, 2011, 6
  • [29] Intensity-modulated radiotherapy planning from limited anatomical information: Is Sim-CT sufficient for planning women with breast cancer receiving intensity-modulated radiotherapy?
    Trouncer, RJ
    Rowbottom, CG
    Budgell, GJ
    Mackay, RI
    Magee, B
    CLINICAL ONCOLOGY, 2005, 17 (05) : 343 - 351
  • [30] Dosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer
    Al-Rahbi, Zakiya Salem
    Al Mandhari, Zahid
    Ravichandran, Ramamoorthy
    Al-Kindi, Fatma
    Davis, Cheriyathmanjiyil Antony
    Bhasi, Saju
    Satyapal, Namrata
    Rajan, Balakrishnan
    JOURNAL OF MEDICAL PHYSICS, 2013, 38 (01) : 22 - 29